Drug intelligence / Profile preview

Folisan

Development stage
Unknown
Lead developer
Sanrey Therapeutics
Modality
Small Molecules
Administration
Oral
01

Overview

Folisan is an oral fixed-dose combination of three active B-vitamins: L-methylfolate (the active form of folate/vitamin B9), mecobalamin (the active form of vitamin B12), and pyridoxal 5-phosphate (the active form of vitamin B6). Developed by Sanrey Therapeutics, Folisan is primarily indicated for the management of nutritional deficiencies and neurological disorders, particularly peripheral neuropathy and diabetic neuropathy. By providing the biologically active forms of these essential vitamins, Folisan bypasses the metabolic conversion steps that can be impaired in certain individuals (such as those with MTHFR polymorphisms). These vitamins work synergistically to support nerve repair, maintain myelin sheath integrity, promote red blood cell production, and reduce elevated homocysteine levels, thereby supporting overall nervous system and cardiovascular health.

Brand names
Folisan
Other names
L-methylfolate + mecobalamin + pyridoxal 5-phosphateL-methylfolate + methylcobalamin + pyridoxal 5-phosphate
02

Targets

DDC (Aromatic L-amino acid decarboxylase)CBS (Cystathionine beta-synthase)MTR (Methionine synthase)

Beyond the preview

Go deeper on Folisan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Folisan.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call